New ASH Summit Encourages Practical, Elevated Dialogue on Emerging Immunotherapies
The ASH Summit on Emerging Immunotherapies for Hematologic Diseases program co-chairs Drs. Catherine Bollard, Rodrigo Calado, Sergio Giralt, and Jeffrey Miller share their
Novel Insights From Comprehensive Genomic Profiling of T Cell Acute Lymphoblastic Leukemia
Dr. Teachey reviews a study that helps expand understanding of T-cell acute lymphoblastic leukemia biology.
Dr. Bennett talks about his journey as a hematologist, mentor, and clinical researcher, while a former protégé, Dr. Liesveld, sheds light on Dr. Bennett's career in academic medicine as well as other athletic and musical talents and interests.
Drs. Gale, Bennett, and Hoffman discuss factors hematologists must keep in mind when diagnosing patients with therapy-related AML or MDS, in order to prevent incorrect therapy decisions.
January-February 2018Volume 15, Issue 1
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology